Skip to main content

menu
menu
person
Search

Specialty Program

Pain Management

Glycemic Regulation

PCSK9s in Interventional Cardiology

PCSK9s in Medical Preventative

PCSK9s in Lipid Medicine & Atherosclerosis Prevention

PCSK9s in Diabetes Management

PCSK9s: A Multi-Specialty Perspective

Specialty Program

Glycemic Regulation

PCSK9s in Diabetes Management

Specialty Program

Congenital Adrenal Hyperplasia (CAH)

Cytokine Immunotherapy

Specialty Program

Parkinson's Disease

Specialty Program

Cytokine Immunotherapy

Extracorporeal Photopheresis (ECP)

Pain Management

Specialty Program

Atopic Dermatitis

Congenital Adrenal Hyperplasia (CAH)

Parkinson's Disease

Pain Management

Glycemic Regulation

Specialty Program

Atopic Dermatitis

Cytokine Immunotherapy

Extracorporeal Photopheresis (ECP)

Specialty Program

Atopic Dermatitis

Cytokine Immunotherapy

Biosimilars for RA

PCSK9s in Interventional Cardiology

PCSK9s in Medical Preventative

PCSK9s in Lipid Medicine & Atherosclerosis Prevention

PCSK9s in Diabetes Management

PCSK9s: A Multi-Specialty Perspective

MAC Lung Disease

Specialty Program

MAC Lung Disease

close

person

Home
Specialties
- Topics
- Cardiology
- Diabetes
- Endocrinology
- Neurology
- Cancer
- Primary Care
- Dermatology
- Biologics
- MAC Lung Disease
Submit A Question

Dr. Daniel SW Tan

Dr. Daniel SW Tan

Medical Oncology
Senior Consultant
National Cancer Centre Singapore
Clinician-Scientist Fellow, The Genome Institute
Singapore

Related Videos

What are the possible limitations of NGS and what is the importance of working with a molecular tumor board?

What are the possible limitations of NGS and what is the importance of working with a molecular tumor board?

What are the possible limitations of NGS and what is the importance of working with a molecular tumor board?

When is the ideal timing for obtaining whole exome sequencing? Is the timing strategy tumor dependent?

When is the ideal timing for obtaining whole exome sequencing? Is the timing strategy tumor dependent?

When is the ideal timing for obtaining whole exome sequencing? Is the timing strategy tumor dependent?

What specific and actionable molecular derangements are identified by NGS to guide targeted therapy?

What specific and actionable molecular derangements are identified by NGS to guide targeted therapy?

What specific and actionable molecular derangements are identified by NGS to guide targeted therapy?

Are all NGS platforms created equally? How are they different?

Are all NGS platforms created equally? How are they different?

Are all NGS platforms created equally? How are they different?

How has the clinical trial landscape for precision oncology changed under the influence of NGS?

How has the clinical trial landscape for precision oncology changed under the influence of NGS?

How has the clinical trial landscape for precision oncology changed under the influence of NGS?

Why is whole genome sequencing with NGS uniquely applicable to patients with NSCLC?

Why is whole genome sequencing with NGS uniquely applicable to patients with NSCLC?

Why is whole genome sequencing with NGS uniquely applicable to patients with NSCLC?

Disclaimer:
Copyright © by CMEducation Resources, LLC All rights reserved. Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Clinical Webcasts®

Powered by BROADCASTMED